Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation
ContributorsSchon, Michael P.; Krahn, Thomas; Schon, Margarete; Rodriguez, Maria-L; Antonicek, Horst; Schultz, Jeanette E.; Ludwig, Ralf J.; Zollner, Thomas Matthias; Bischoff, Erwin; Bremm, Klaus-D; Schramm, Matthias; Henninger, Kerstin; Kaufmann, Roland; Gollnick, Harald P. M.; Parker, Christina M.; Boehncke, Wolf-Henning
Published inNature medicine, vol. 8, no. 4, p. 366-372
Publication date2002
Abstract
Keywords
- Animals
- Anti-Inflammatory Agents, Non-Steroidal/chemistry/*pharmacology
- Cell Adhesion/drug effects
- Cell Movement/drug effects
- E-Selectin/*drug effects
- Female
- Humans
- Leukocytes/*drug effects
- Macrolides/chemistry/*pharmacology
- Mice
- Mice, Inbred C57BL
- Mice, SCID
- Models, Molecular
- Oligosaccharides/chemistry
- Psoriasis/*drug therapy/pathology
- Skin Transplantation
- Streptomyces/chemistry
- Transplantation, Heterologous
Affiliation Not a UNIGE publication
Citation (ISO format)
SCHON, Michael P. et al. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. In: Nature medicine, 2002, vol. 8, n° 4, p. 366–372. doi: 10.1038/nm0402-366
Main files (1)
Article
Identifiers
- PID : unige:29790
- DOI : 10.1038/nm0402-366
- PMID : 11927942
ISSN of the journal1078-8956